한글목차

본 보고서는 아토피 피부염 치료제를 지원하는 Medical Affeirs 팀의 경쟁력과 명성을 유럽 각국 피부과 의사의 피드백을 바탕으로 분석한 것입니다. 의사가 Medical Affairs 팀과 어떻게 연관되어 있는지, 어떤 서비스가 가장 중시되는지, 제품별 만족도, 선호하는 커뮤니케이션 수단 및 빈도에 대한 자세한 인사이트를 제공합니다. 또한, Medical Affeirs 팀이 향후 치료 환경에서 의사의 요구에 부응하기 위해 강화해야 할 영역도 밝혔습니다.

주요 질문

• 1. 의사는 어느 정도의 빈도로 Medical Affeirs 팀과 접촉하고 있으며, 그 빈도가 증가하거나 감소하고 있는가?
• 2. 의사는 현재 Medical Affairs 팀이 제공하는 서비스를 어떻게 활용하고 있는가?
• 3. 의사들에게 Medical Affeirs 지원에서 가장 중요한 것은 무엇인가? 또, 그 지원에 대한 만족도는 어느 정도인가?
• 4. 의사가 Medical Affairs 팀과의 상호 작용을 선호하는 수단은 무엇인가? 또한 원하는 접촉 빈도는 어느 정도입니까?
• 5. Medical Affairs 팀은 의사의 요구에 얼마나 대응하고 있는가?
• 6. 특정 브랜드에서 Medical Affairs 팀은 기대치를 밑돌고 있는가?
• 7. 미래에 의사의 요구에 더 잘 대처하기 위해 Medical Affairs 서비스는 어떻게 개선될 수 있는가?
• 8. 경쟁사의 Medical Affairs 팀의 강점과 약점은 각각 어디에 있는가?

주요 브랜드

영문목차

This report examines the competitive performance and reputation of Medical Affairs teams supporting therapies for atopic dermatitis, based on feedback from dermatologists across Europe. It provides detailed insights into how physicians currently engage with Medical Affairs teams, the services they value most, satisfaction levels by product, and preferred channels and frequency of interaction. The findings also highlight areas where Medical Affairs teams can strengthen their support to better meet physician needs in an evolving treatment landscape.

Key Questions Answered:

• 1. How frequently do physicians interact with Medical Affairs teams, and is the frequency of this interaction increasing or decreasing?
• 2. In what ways do physicians currently use the services provided by Medical Affairs teams?
• 3. What aspects of Medical Affairs support are most important to physicians and how satisfied are they with the support provided?
• 4. What are the preferred mediums for interactions between physicians and Medical Affairs teams and what is the preferred frequency of these interactions?
• 5. How successful are Medical Affairs teams at meeting physician needs?
• 6. Are Medical Affairs teams falling short or exceeding goals with any particular brands?
• 7. How can Medical Affairs services be improved to better meet the needs of physicians in the future?
• 8. In what areas are your competitors' Medical Affairs teams weakest and strongest?

Key Brands:

Methodology:

FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.